CIRM-funded clinical trial takes a combination approach to treating deadly blood cancers

A diagnosis of cancer often means a tough road ahead, with surgery, chemotherapy and radiation used to try and kill the tumor. Even then, sometimes cancer cells manage to survive and return later, spreading throughout the body. Now researchers at UC San Diego and Oncternal Therapeutics are teaming up with a combination approach they hope … Continue reading CIRM-funded clinical trial takes a combination approach to treating deadly blood cancers

New stem cell approach targeting deadly blood cancers

Every four minutes someone in the US is diagnosed with a blood cancer. It might be lymphoma or leukemia, myeloma or myelodysplastic syndromes (MDS). While we have made great strides in treating some of these over the years, we still have a long way to go. Need proof? Well, every nine minutes someone in the US … Continue reading New stem cell approach targeting deadly blood cancers

Stem cell stories that caught our eye: young blood, cord blood, and blood cancers

Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Pinning down young blood’s rejuvenating power. A trio of studies in the past week provided more evidence that giving older mice the blood of younger … Continue reading Stem cell stories that caught our eye: young blood, cord blood, and blood cancers

Through their lens: Alexander Seutin learns how computer technology can help unlock secrets of blood cancers

This summer we’re sponsoring high school interns in stem cell labs throughout California. We asked those students to contribute to our Instagram photos and YouTube videos about life in the lab, and write about their experiences.Alexander Seutin did a stem cell research internship this summer in the laboratory of Ravi Majeti at Stanford University. This summer I worked at … Continue reading Through their lens: Alexander Seutin learns how computer technology can help unlock secrets of blood cancers

Through their lens: Ted Zhu learns the thrill of the "aha!" moment while working on blood cancer

This summer we’re sponsoring high school interns in stem cell labs throughout California. We asked those students to contribute to our Instagram photos and YouTube videos about life in the lab, and write about their experiences.Ted Zhu will be a junior at Walnut High School.  He works in Dr. Ren-Jang Lin’s lab, where he is designing a site-specific nuclease … Continue reading Through their lens: Ted Zhu learns the thrill of the "aha!" moment while working on blood cancer

Through their lens: Ted Zhu learns the thrill of the “aha!” moment while working on blood cancer

This summer we’re sponsoring high school interns in stem cell labs throughout California. We asked those students to contribute to our Instagram photos and YouTube videos about life in the lab, and write about their experiences.Ted Zhu will be a junior at Walnut High School.  He works in Dr. Ren-Jang Lin’s lab, where he is designing a site-specific nuclease … Continue reading Through their lens: Ted Zhu learns the thrill of the “aha!” moment while working on blood cancer

Blood stem cell expansion expands treatment options for cancer patients

Bone marrow transplants have been used for decades to treat various types of cancers such as leukemia and multiple myeloma, as well as other blood disorders such as anemia. Our bone marrow is responsible for making hematopoietic stem cells (HSCs), which develop into mature blood cells, like white cells (which fight infection) and red cells … Continue reading Blood stem cell expansion expands treatment options for cancer patients

Therapies Targeting Cancer, Deadly Immune Disorder and Life-Threatening Blood Condition Get Almost $32 Million Boost from CIRM Board

An innovative therapy that uses a patient’s own immune system to attack cancer stem cells is one of three new clinical trials approved for funding by CIRM’s Governing Board. Researchers at the Stanford University School of Medicine were awarded $11.9 million to test their Chimeric Antigen Receptor (CAR) T Cell Therapy in patients with B … Continue reading Therapies Targeting Cancer, Deadly Immune Disorder and Life-Threatening Blood Condition Get Almost $32 Million Boost from CIRM Board